Skip to main content

Impact of COVID-19 in Cancer

2020 will be remembered in history as the year of the pandemic. Thousands of people have been infected by the SARS-CoV-2 coronavirus (>500,000 infected) and many deaths (>25,000) resulting from COVID-19, particularly older people with chronic diseases (including cardiovascular and diabetes) and cancer. COVID-19 highlighted the weakness of health systems in several locations, including those with strong welfare systems (e.g. Europe and USA). The speed of the transmission and the high frequency of acute respiratory distress syndrome (ARDS) requiring subintensive and intensive care units (ICU) demonstrated the inadequacy of their preparedness to deal with acute epidemic diseases. The fast track solution was to re-introduce the battle-field war strategies: the triage to decide those to be treated, based on age (in some Italian hospital the older people admitted were 55-year old) or on health (in USA disabilities are considered as selection criteria).

At the same time we had few very encouraging positive findings:

  1. The capacity to establish in 10 days hospitals and shelters for the care of thousands of patients, even at intensive and sub-intensive level
  2. The potential to develop preventive vaccines in few months, the General Scientist Dr Chen Wei, produced the vaccine and tested it on her arm on March 5th
  3. The discovery of the efficacy of anti-IL6-IL6R axis to solve ARDS and to drastically reduce or even prevent ICU stay.

This series welcomes articles on all COVID-19-related topics, in particular:

  • Molecular characterization of the SARS-CoV-2 to characterize the genetic evolution of the virus and to identify variants for pathogenicity purposes as well as immune preventive strategies;
  • Immunology, molecular and systems biology studies aimed to early diagnosis and innovative treatment of SARS-CoV-2-related disease in order to mitigate their huge death burden;
  • Preclinical and clinical studies to identify effective molecules (innovative molecules or repurposing drugs) for treatment of COVID-19 severe ARDS.

Editors: 

Dr Maria Lina Tornesello, Istituto Nazionale Tumori, Naples, Italy

Franco M Buonaguro, Istituto Nazionale Tumori, Naples, Italy

  1. Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course...

    Authors: Dominic Kaddu-Mulindwa, Lorenz Thurner, Moritz Bewarder, Niels Murawski, Manfred Ahlgrimm, Thorsten Pfuhl, Barbara Gärtner, Sigrun Smola and Stephan Stilgenbauer

    Citation: Infectious Agents and Cancer 2021 16:17

    Content type: Letter to the Editor

    Published on:

  2. The medical community has been deeply involved in fighting the Coronavirus disease 2019 (COVID-19) pandemic and, as a consequence, the care of non-COVID-19 patients has been impacted. However, the treatment of...

    Authors: Francesco Longo, Eleonora M. C. Trecca, Aurelio D’Ecclesia, Chiara Copelli, Karim Tewfik, Alfonso Manfuso, Nicola Pederneschi, Annalisa Mastromatteo, Matteo Aldo Russo, Antonio Pansini, Luca M. Lacerenza, Pier Gerardo Marano and Lazzaro Cassano

    Citation: Infectious Agents and Cancer 2021 16:9

    Content type: Review

    Published on:

  3. COVID-19 has caused great concern for patients with underlying medical conditions. We aimed to determine the prognosis of patients with current or previous cancer with either a PCR-confirmed COVID-19 infection...

    Authors: Majid Sorouri, Amir Kasaeian, Helia Mojtabavi, Amir Reza Radmard, Shadi Kolahdoozan, Amir Anushiravani, Bardia Khosravi, Seyed Mohammad Pourabbas, Masoud Eslahi, Azin Sirusbakht, Marjan Khodabakhshi, Fatemeh Motamedi, Fatemeh Azizi, Reza Ghanbari, Zeynab Rajabi, Ali Reza Sima…

    Citation: Infectious Agents and Cancer 2020 15:74

    Content type: Research Article

    Published on:

  4. COVID-19 pandemic following the outbreak in China and Western Europe, where it finally lost the momentum, is now devastating North and South America. It has not been identified the reason and the molecular mec...

    Authors: Franco M. Buonaguro, Gerardo Botti, Paolo Antonio Ascierto, Sandro Pignata, Franco Ionna, Paolo Delrio, Antonella Petrillo, Ernesta Cavalcanti, Maurizio Di Bonito, Sisto Perdonà, Michelino De Laurentiis, Francesco Fiore, Raffaele Palaia, Francesco Izzo, Stefania D’Auria, Virginia Rossi…

    Citation: Infectious Agents and Cancer 2020 15:69

    Content type: Methodology

    Published on:

\